Interaction of physalaemin, substance P, and eledoisin with specific membrane receptors on pancreatic acinar cells.
We have prepared 125I-labeled physalaemin and have examined the kinetics, stoichiometry, and chemical specificity with which the labeled peptide binds to dispersed acini from guinea pig pancreas. Binding of 125I-labeled physalaemin was saturable, temperature-dependent, and reversible and reflected interaction of the labeled peptide with a single class of binding sites on the plasma membrane of pancreatic acinar cells. Each acinar cell possessed approximately 500 binding sites, and binding of the tracer to these sites could be inhibited by physalaemin [concentration for half-maximal effect (Kd), 2 nM], substance P (Kd, 5 nM), or eledoisin (Kd, 300 nM) but not by cholecystokinin, caerulein, bombesin, litorin, gastrin, secretin, vasoactive intestinal peptide, glucagon, somatostatin, neurotensin, bovine pancreatic polypeptide, leucine-enkephalin, methionine-enkephalin, atropine, or carbamylcholine. With physalaemin, substance P, and eledoisin, there was a close correlation between the relative potency for inhibition of binding of labeled physalaemin and that for stimulation of amylase secretion. For a given peptide, however, a 3-fold higher concentration was required for half-maximal inhibition of binding than for half-maximal stimulation of amylase secretion, calcium outflux, or cyclic GMP accumulation. These results indicate that dispersed acini from guinea pig pancreas possess a single class of receptors that interact with physalaemin, substance P, and eledoisin and that occupation of 45% of these receptors will cause a maximal biological response.
D000681:Amylases / Q000378:metabolism; D000818:Animals; D001667:Binding, Competitive; D001693:Biological Transport, Active; D002118:Calcium / Q000378:metabolism; D006152:Cyclic GMP / Q000378:metabolism; D004600:Eledoisin / Q000378:metabolism*; D006168:Guinea Pigs; D007700:Kinetics; D007705:Kinins / Q000378:metabolism*; D008297:Male; D010179:Pancreas / Q000378:metabolism*; D010803:Physalaemin / Q000378:metabolism*; D011955:Receptors, Drug / Q000378:metabolism*; D013373:Substance P / Q000378:metabolism*
D007705:Kinins; D011955:Receptors, Drug; D010803:Physalaemin; D013373:Substance P; D004600:Eledoisin; D000681:Amylases; D006152:Cyclic GMP; D002118:Calcium